Non-Small Cell Lung Cancer

Addressing Learning Curves in Rare NSCLC Subtypes and Targeted Therapy Use: Jorge Nieva, MD

Overcoming Barriers to Molecular Testing in NSCLC Care: Jorge Nieva, MD

Clinical Considerations for Immunotherapy Sequencing in NSCLC: Lauren Antrim, MD

Balancing Safety, Cost, and Duration in Immunotherapy for NSCLC: Lauren Antrim, MD

Patient Engagement Can Help Drive More Comprehensive NSCLC Testing: Julia Rotow, MD

Cutting-Edge and Basic Treatments Can Work in Tandem to Address NSCLC: Frank Weinberg, MD, PhD

Addressing Financial and Socioeconomic Barriers to Precision NSCLC Care: Jonathan Thompson, MD, MS

Weighing Relapse Risk Against Benefit in Advanced NSCLC Immunotherapy: Jonathan Thompson, MD, MS

Outcomes in NSCLC Rely on Equitable Access to Treatment: Frank Weinberg, MD, PhD

Navigating Perioperative Immunotherapy Decisions in Lung Cancer Care: Jonathan Thompson, MD, MS